Thread by @gregggonsalves, So I am going to be direct here. Janet Woodcock's role in [...]

So I am going to be direct here. Janet Woodcock's role in the Exondys approval, the delays in Plan B OTC approval and cover-up on Avandia disqualify her for the post of @US_FDA commissioner. Corporate backed disease groups and Pharma love her because she does their bidding. 1/

Don't know the Exondys affair? Here is one piece on the ugly tale. Didn't serve patients, nor the public health, went against all scientific advice. Woodcock front and center in this mess. 2/ https://www.nature.com/articles/nm.4234

Railroading at the FDA

The US Food and Drug Administration approved a muscular-dystrophy drug against the scientific advice of its own staff and advisors. Despite leadership's attempts to downplay the controversy, doubts...

https://www.nature.com/articles/nm.4234

Then on Plan B as over-the-counter? Woodcock warned of teen sex cults if approved. Yes. Yes. She did. 3/ https://www.nytimes.com/2006/05/07/magazine/07contraception.html

Contra-Contraception (Published 2006)

A growing number of conservatives see birth control as part of an ailing culture that overemphasizes sex and devalues human life. Is this the beginning of the next culture war?

https://www.nytimes.com/2006/05/07/magazine/07contraception.html

And Avandia. Woodcock and CDER made a tragic mistake and tried to sweep it under the carpet. 4/ https://www.forbes.com/sites/matthewherper/2013/05/23/steven-nissen-the-hidden-agenda-behind-the-fdas-avandia-hearings/?sh=2e13cb045cfb

Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings

Is the FDA holding a two-day panel with the goal of making its leadership look better with regard to the withdrawn diabetes drug? The cardiologist who blew the whistle on Avandia wants to know.

https://www.forbes.com/sites/matthewherper/2013/05/23/steven-nissen-the-hidden-agenda-behind-the-fdas-avandia-hearings/?sh=2e13cb045cfb

And the disease groups speaking out for Dr. Woodcock? Many of them get most of their funding from the pharmaceutical industry. 5/ https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2598094

Advocacy Organizations, Industry Funding, and Conflicts of Interest

This survey study examines the nature of industry funding and partnerships between patient advocacy organizations and for-profit companies in the United States.

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2598094

And often don't disclose this funding. 6/ https://jamanetwork.com/journals/jama/fullarticle/645619

Study: Few Advocacy Groups Disclose Grants From Drug Companies

Influential disease-specific advocacy organizations that call for more research and access to treatment often do not disclose funding they receive from pharmaceutical companies that make the very...

https://jamanetwork.com/journals/jama/fullarticle/645619

So reporters, please vet these candidates with a little more scrutiny--all of them--rather than making this about the tally of endorsements. The situation with Woodcock is just appalling. Exondys. Plan B. Avandia. Just scratching the surface. 7/

. @joannekenen, @abettel, @jasonmillman, @lmorello_dc, @sarasmarley, @ZacharyBrennan, @adamcancryn, @tucker_doherty, @briannaehley, @dancgoldberg, @davidalim, @SusannahLuthi, @aliceollstein, @owermohle, @carmenpaun, @ravindranize, @rachel_roubein, @dariustahir end/

You can follow @gregggonsalves.

Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: